Antino Allen
Concepts (215)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hippocampus | 24 | 2023 | 242 | 9.390 |
Why?
| Cognition | 13 | 2023 | 348 | 4.140 |
Why?
| Behavior, Animal | 9 | 2021 | 200 | 3.590 |
Why?
| Cosmic Radiation | 9 | 2021 | 38 | 2.880 |
Why?
| Dendrites | 6 | 2020 | 28 | 2.670 |
Why?
| Dendritic Spines | 10 | 2020 | 21 | 2.460 |
Why?
| Cyclophosphamide | 4 | 2021 | 172 | 2.290 |
Why?
| Oxygen | 4 | 2021 | 361 | 2.220 |
Why?
| Mice, Inbred C57BL | 32 | 2022 | 1999 | 2.100 |
Why?
| Neurons | 5 | 2021 | 486 | 1.760 |
Why?
| Mice | 34 | 2023 | 6413 | 1.700 |
Why?
| Animals | 43 | 2023 | 14385 | 1.510 |
Why?
| Doxorubicin | 3 | 2021 | 259 | 1.480 |
Why?
| Fluorouracil | 3 | 2020 | 61 | 1.440 |
Why?
| Maze Learning | 7 | 2021 | 55 | 1.430 |
Why?
| Social Behavior | 2 | 2020 | 85 | 1.390 |
Why?
| Methotrexate | 2 | 2020 | 73 | 1.310 |
Why?
| Hydrogen | 2 | 2018 | 13 | 1.280 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2022 | 1056 | 1.250 |
Why?
| Memory | 4 | 2020 | 124 | 0.960 |
Why?
| Isothiocyanates | 1 | 2023 | 25 | 0.920 |
Why?
| Fertility Preservation | 1 | 2023 | 7 | 0.920 |
Why?
| Sirtuin 3 | 1 | 2023 | 17 | 0.900 |
Why?
| Space Flight | 3 | 2021 | 37 | 0.900 |
Why?
| Cranial Irradiation | 2 | 2020 | 24 | 0.870 |
Why?
| Dentate Gyrus | 8 | 2020 | 17 | 0.860 |
Why?
| Brain | 6 | 2021 | 1387 | 0.850 |
Why?
| Dioxolanes | 1 | 2022 | 13 | 0.840 |
Why?
| Neuroprotective Agents | 1 | 2022 | 125 | 0.760 |
Why?
| Metalloporphyrins | 1 | 2020 | 13 | 0.740 |
Why?
| Neuronal Plasticity | 2 | 2017 | 58 | 0.710 |
Why?
| Paclitaxel | 1 | 2020 | 103 | 0.710 |
Why?
| Solar Activity | 2 | 2021 | 8 | 0.700 |
Why?
| Thiotepa | 1 | 2019 | 5 | 0.700 |
Why?
| CA1 Region, Hippocampal | 5 | 2020 | 28 | 0.670 |
Why?
| Antineoplastic Agents, Alkylating | 1 | 2019 | 74 | 0.670 |
Why?
| Dose-Response Relationship, Radiation | 10 | 2019 | 204 | 0.660 |
Why?
| Oxidation-Reduction | 1 | 2020 | 382 | 0.660 |
Why?
| Oxygen Radioisotopes | 1 | 2018 | 16 | 0.650 |
Why?
| Radiation Injuries | 3 | 2015 | 153 | 0.640 |
Why?
| Male | 29 | 2023 | 27312 | 0.630 |
Why?
| Cytarabine | 1 | 2017 | 39 | 0.630 |
Why?
| Memory, Short-Term | 2 | 2019 | 85 | 0.630 |
Why?
| Antimetabolites, Antineoplastic | 1 | 2017 | 39 | 0.630 |
Why?
| Eflornithine | 2 | 2014 | 8 | 0.620 |
Why?
| Tissue Fixation | 1 | 2017 | 35 | 0.610 |
Why?
| Antioxidants | 5 | 2023 | 297 | 0.590 |
Why?
| Staining and Labeling | 1 | 2017 | 106 | 0.590 |
Why?
| Receptors, CCR2 | 2 | 2013 | 14 | 0.580 |
Why?
| Cognition Disorders | 3 | 2015 | 240 | 0.570 |
Why?
| Oxidative Stress | 6 | 2023 | 958 | 0.570 |
Why?
| Neoplasms | 2 | 2023 | 1315 | 0.510 |
Why?
| Brain Injuries | 2 | 2014 | 183 | 0.510 |
Why?
| Immunosuppressive Agents | 1 | 2016 | 248 | 0.500 |
Why?
| Up-Regulation | 1 | 2016 | 508 | 0.500 |
Why?
| Radiation Injuries, Experimental | 2 | 2014 | 105 | 0.500 |
Why?
| Whole-Body Irradiation | 5 | 2017 | 160 | 0.490 |
Why?
| Antineoplastic Agents | 1 | 2023 | 1300 | 0.480 |
Why?
| Learning | 1 | 2015 | 175 | 0.470 |
Why?
| Electric Fish | 1 | 2012 | 1 | 0.450 |
Why?
| Nerve Regeneration | 1 | 2012 | 24 | 0.450 |
Why?
| Central Nervous System | 1 | 2013 | 85 | 0.440 |
Why?
| Iron | 6 | 2015 | 158 | 0.430 |
Why?
| Spinal Cord Injuries | 1 | 2012 | 61 | 0.420 |
Why?
| Aging | 2 | 2019 | 784 | 0.410 |
Why?
| Neurogenesis | 3 | 2020 | 30 | 0.400 |
Why?
| Female | 11 | 2023 | 28418 | 0.400 |
Why?
| Disease Models, Animal | 3 | 2023 | 1639 | 0.370 |
Why?
| Age Factors | 1 | 2014 | 1195 | 0.370 |
Why?
| Time Factors | 5 | 2019 | 3212 | 0.370 |
Why?
| Hematopoietic Stem Cells | 3 | 2017 | 215 | 0.350 |
Why?
| Mitochondria | 3 | 2023 | 489 | 0.340 |
Why?
| Receptors, AMPA | 2 | 2019 | 17 | 0.330 |
Why?
| Heavy Ions | 4 | 2015 | 17 | 0.330 |
Why?
| Cell Proliferation | 1 | 2012 | 1096 | 0.320 |
Why?
| Radiation, Ionizing | 3 | 2019 | 120 | 0.320 |
Why?
| Synapses | 2 | 2019 | 90 | 0.320 |
Why?
| Receptors, N-Methyl-D-Aspartate | 2 | 2019 | 121 | 0.300 |
Why?
| Proteomics | 2 | 2020 | 343 | 0.300 |
Why?
| Exploratory Behavior | 2 | 2018 | 39 | 0.300 |
Why?
| Gene Expression Regulation | 3 | 2018 | 1062 | 0.290 |
Why?
| RNA, Messenger | 2 | 2022 | 1202 | 0.290 |
Why?
| Electromagnetic Radiation | 3 | 2016 | 4 | 0.290 |
Why?
| Signal Transduction | 3 | 2022 | 1753 | 0.250 |
Why?
| Quality of Life | 2 | 2022 | 922 | 0.250 |
Why?
| Cytokines | 2 | 2019 | 676 | 0.240 |
Why?
| Inflammation | 2 | 2022 | 674 | 0.240 |
Why?
| Sulfoxides | 1 | 2023 | 28 | 0.230 |
Why?
| Animals, Wild | 1 | 2023 | 11 | 0.230 |
Why?
| Histone Deacetylases | 1 | 2023 | 47 | 0.230 |
Why?
| Lung | 3 | 2016 | 507 | 0.220 |
Why?
| Ovary | 1 | 2023 | 105 | 0.220 |
Why?
| Extraterrestrial Environment | 2 | 2021 | 8 | 0.220 |
Why?
| Reproduction | 1 | 2023 | 56 | 0.220 |
Why?
| Superoxide Dismutase | 1 | 2023 | 125 | 0.220 |
Why?
| Cell Separation | 1 | 2021 | 107 | 0.200 |
Why?
| Breast Neoplasms | 2 | 2022 | 1248 | 0.200 |
Why?
| Education, Graduate | 1 | 2021 | 12 | 0.200 |
Why?
| Glucose Transporter Type 1 | 1 | 2020 | 16 | 0.190 |
Why?
| rac1 GTP-Binding Protein | 1 | 2020 | 12 | 0.190 |
Why?
| School Admission Criteria | 1 | 2021 | 37 | 0.190 |
Why?
| Sirtuins | 1 | 2020 | 12 | 0.190 |
Why?
| Cardiovascular System | 1 | 2021 | 50 | 0.190 |
Why?
| Epigenesis, Genetic | 2 | 2014 | 399 | 0.190 |
Why?
| Radiation Dosage | 3 | 2015 | 170 | 0.190 |
Why?
| Amyloid beta-Peptides | 1 | 2020 | 82 | 0.180 |
Why?
| Silver Staining | 2 | 2016 | 8 | 0.180 |
Why?
| Minority Groups | 1 | 2021 | 135 | 0.180 |
Why?
| Chemotherapy, Adjuvant | 1 | 2020 | 119 | 0.180 |
Why?
| Injections, Intraperitoneal | 1 | 2019 | 59 | 0.170 |
Why?
| Astrocytes | 1 | 2020 | 142 | 0.170 |
Why?
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2019 | 25 | 0.170 |
Why?
| Protein Subunits | 1 | 2019 | 85 | 0.170 |
Why?
| Relative Biological Effectiveness | 1 | 2018 | 7 | 0.170 |
Why?
| Osteogenesis | 1 | 2021 | 377 | 0.170 |
Why?
| Flow Cytometry | 1 | 2021 | 546 | 0.170 |
Why?
| Reactive Oxygen Species | 3 | 2017 | 491 | 0.170 |
Why?
| Proton Therapy | 1 | 2018 | 9 | 0.160 |
Why?
| Radiation-Protective Agents | 1 | 2020 | 116 | 0.160 |
Why?
| Osteoclasts | 1 | 2021 | 469 | 0.160 |
Why?
| Leukocyte Count | 1 | 2018 | 77 | 0.160 |
Why?
| Movement | 1 | 2019 | 111 | 0.160 |
Why?
| Injections, Spinal | 1 | 2017 | 19 | 0.160 |
Why?
| Bromodeoxyuridine | 2 | 2014 | 20 | 0.160 |
Why?
| CA3 Region, Hippocampal | 1 | 2017 | 5 | 0.160 |
Why?
| Leukocytes | 1 | 2017 | 85 | 0.150 |
Why?
| Blood Glucose | 1 | 2020 | 488 | 0.150 |
Why?
| Models, Animal | 1 | 2018 | 255 | 0.150 |
Why?
| DNA Methylation | 3 | 2016 | 574 | 0.150 |
Why?
| Stress, Psychological | 1 | 2019 | 269 | 0.150 |
Why?
| Long Interspersed Nucleotide Elements | 1 | 2016 | 41 | 0.140 |
Why?
| Radio Waves | 1 | 2016 | 6 | 0.140 |
Why?
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 105 | 0.140 |
Why?
| Pattern Recognition, Visual | 1 | 2015 | 22 | 0.140 |
Why?
| Cytoskeletal Proteins | 2 | 2013 | 58 | 0.140 |
Why?
| Alzheimer Disease | 1 | 2020 | 367 | 0.140 |
Why?
| Microglia | 2 | 2014 | 137 | 0.130 |
Why?
| Bone Marrow | 1 | 2017 | 411 | 0.130 |
Why?
| Catalase | 1 | 2015 | 74 | 0.130 |
Why?
| Nerve Tissue Proteins | 2 | 2013 | 199 | 0.120 |
Why?
| Thioredoxins | 1 | 2014 | 30 | 0.120 |
Why?
| Silicon | 1 | 2014 | 8 | 0.120 |
Why?
| Radioisotopes | 1 | 2014 | 19 | 0.120 |
Why?
| Apoptosis | 2 | 2017 | 1300 | 0.120 |
Why?
| Gene Expression Profiling | 1 | 2018 | 1138 | 0.110 |
Why?
| Immunohistochemistry | 2 | 2014 | 1089 | 0.110 |
Why?
| Cell Count | 1 | 2012 | 181 | 0.110 |
Why?
| Fear | 1 | 2013 | 87 | 0.110 |
Why?
| Cell Differentiation | 1 | 2015 | 720 | 0.100 |
Why?
| Protons | 3 | 2015 | 81 | 0.100 |
Why?
| Cell Survival | 1 | 2012 | 657 | 0.090 |
Why?
| Humans | 6 | 2023 | 54246 | 0.080 |
Why?
| Mice, Transgenic | 2 | 2020 | 656 | 0.070 |
Why?
| Gymnotiformes | 1 | 2004 | 1 | 0.060 |
Why?
| Nitrergic Neurons | 1 | 2004 | 1 | 0.060 |
Why?
| Repetitive Sequences, Nucleic Acid | 2 | 2015 | 92 | 0.060 |
Why?
| Citrulline | 1 | 2004 | 98 | 0.060 |
Why?
| DNA Damage | 2 | 2017 | 357 | 0.060 |
Why?
| Nitric Oxide | 1 | 2004 | 298 | 0.050 |
Why?
| Cells, Cultured | 2 | 2017 | 1737 | 0.050 |
Why?
| Analysis of Variance | 2 | 2013 | 635 | 0.050 |
Why?
| Neuropsychological Tests | 2 | 2013 | 363 | 0.050 |
Why?
| Astronauts | 1 | 2021 | 5 | 0.050 |
Why?
| Mice, Inbred BALB C | 1 | 2021 | 368 | 0.050 |
Why?
| Radiation Protection | 1 | 2021 | 55 | 0.050 |
Why?
| Universities | 1 | 2021 | 164 | 0.050 |
Why?
| Risk | 1 | 2020 | 343 | 0.040 |
Why?
| Peptide Fragments | 1 | 2020 | 242 | 0.040 |
Why?
| Tissue Extracts | 1 | 2019 | 13 | 0.040 |
Why?
| Educational Measurement | 1 | 2021 | 232 | 0.040 |
Why?
| Students | 1 | 2021 | 207 | 0.040 |
Why?
| Inflammation Mediators | 1 | 2019 | 128 | 0.040 |
Why?
| Injections, Intravenous | 1 | 2018 | 148 | 0.040 |
Why?
| Ovariectomy | 1 | 2018 | 125 | 0.040 |
Why?
| Gene Expression | 1 | 2020 | 664 | 0.040 |
Why?
| Insulin | 1 | 2020 | 510 | 0.040 |
Why?
| Drug Synergism | 1 | 2018 | 171 | 0.040 |
Why?
| Biomedical Research | 1 | 2021 | 240 | 0.040 |
Why?
| DNA Repair | 1 | 2018 | 202 | 0.040 |
Why?
| Azacitidine | 1 | 2016 | 37 | 0.040 |
Why?
| Motor Activity | 1 | 2018 | 247 | 0.040 |
Why?
| Ferrous Compounds | 1 | 2016 | 11 | 0.040 |
Why?
| Interleukin-13 | 1 | 2015 | 16 | 0.030 |
Why?
| Linear Energy Transfer | 1 | 2015 | 17 | 0.030 |
Why?
| Cell Cycle | 1 | 2017 | 275 | 0.030 |
Why?
| Synaptosomes | 1 | 2015 | 13 | 0.030 |
Why?
| Arkansas | 1 | 2021 | 2094 | 0.030 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2020 | 481 | 0.030 |
Why?
| Long-Term Potentiation | 1 | 2014 | 26 | 0.030 |
Why?
| Gene Dosage | 1 | 2014 | 91 | 0.030 |
Why?
| Pulmonary Fibrosis | 1 | 2014 | 20 | 0.030 |
Why?
| Neoplasms, Radiation-Induced | 1 | 2014 | 42 | 0.030 |
Why?
| Lung Injury | 1 | 2014 | 25 | 0.030 |
Why?
| Histones | 1 | 2016 | 335 | 0.030 |
Why?
| Iron Radioisotopes | 1 | 2013 | 1 | 0.030 |
Why?
| Phosphopyruvate Hydratase | 1 | 2013 | 7 | 0.030 |
Why?
| Electroshock | 1 | 2013 | 9 | 0.030 |
Why?
| Freezing Reaction, Cataleptic | 1 | 2013 | 8 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2015 | 746 | 0.030 |
Why?
| Polyamines | 1 | 2012 | 10 | 0.030 |
Why?
| Spatial Behavior | 1 | 2012 | 13 | 0.030 |
Why?
| Swimming | 1 | 2012 | 30 | 0.030 |
Why?
| Obesity | 1 | 2020 | 1197 | 0.030 |
Why?
| Young Adult | 1 | 2021 | 4308 | 0.020 |
Why?
| Golgi Apparatus | 1 | 2012 | 120 | 0.020 |
Why?
| Mice, Knockout | 1 | 2013 | 926 | 0.020 |
Why?
| Enzyme Inhibitors | 1 | 2012 | 446 | 0.020 |
Why?
| Lung Neoplasms | 1 | 2014 | 642 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2013 | 2387 | 0.020 |
Why?
| Electric Organ | 1 | 2004 | 2 | 0.020 |
Why?
| Avoidance Learning | 1 | 2004 | 18 | 0.020 |
Why?
| Adult | 1 | 2021 | 14182 | 0.020 |
Why?
| Tissue Distribution | 1 | 2004 | 178 | 0.020 |
Why?
| Nitric Oxide Synthase | 1 | 2004 | 102 | 0.020 |
Why?
| Perception | 1 | 2004 | 142 | 0.010 |
Why?
|
|
Allen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|